Combination of CDNF and Deep Brain Stimulation Decreases Neurological Deficits in Late-stage Model Parkinson's Disease [PDF]
, 2018 Several neurotrophic factors ( NTF) are shown to be neuroprotective and neurorestorative in pre-clinical animal models for Parkinson's disease ( PD), particularly in models where striatal dopamine neuron innervation partially exists.
Airavaara, Mikko +10 more
core +1 more source
Improvement of Tardive Dyskinesias with Olanzapine [PDF]
, 2023 Sara Echater, Bouchra Oneib
openalex +1 more source
Distinction and mutual Influences between Parkinson's Disease‐related and unrelated Chronic Pain
Movement Disorders Clinical Practice, EarlyView.Abstract Background Chronic pain (i.e. > 3 months) is a common nonmotor symptom in patients with Parkinson's disease (PD), but the attribution to PD is critical for further treatment. Objectives We explored the PD Pain Classification System (PD‐PCS) criteria for the diagnosis of PD‐related pain and mutual influences between PD‐related and PD‐unrelated ...
Jonathan Hunger +11 more
wiley +1 more source
Facemask usage during the COVID-19 pandemic among people with primary ciliary dyskinesia: a participatory project [PDF]
, 2021 Eva S.L. Pedersen +9 more
openalex +1 more source
Adaptive Deep Brain Stimulation Benefits: Younger Patients with Persistent Wearing‐off Symptoms
Movement Disorders Clinical Practice, EarlyView.Abstract Background Parkinson's disease (PD) often involves motor fluctuations and dyskinesia, which are difficult to manage with medication alone. Conventional deep brain stimulation (cDBS) effectively alleviates symptoms but has limitations, including the challenge of balancing therapeutic effects against potential side effects, as well as limited ...
Takuto Emura +11 more
wiley +1 more source
Abnormal involuntary movement scale in tardive dyskinesia: Minimal clinically important difference [PDF]
, 2019 Mark Stacy +6 more
openalex +1 more source
Ethnic and Gender Disparities in Access to Deep Brain Stimulation Surgery for Parkinson's Disease
Movement Disorders Clinical Practice, EarlyView.Abstract Background Deep brain stimulation (DBS) is an established treatment for Parkinson's disease (PD) in appropriately selected patients. DBS may be underused in certain patient populations, especially women and racialized groups. Barriers and biases to receiving DBS that could account for underuse among these groups are not well studied in Canada.
Fang Ba +14 more
wiley +1 more source
Movement Disorders Clinical Practice, EarlyView.Abstract Background Overcoming existing access barriers is crucial for better‐specialized health care of patients with Parkinson's disease (PD). Objective The aim of the study was to compare the access and visit quality/acceptability between in‐office and virtual telemedicine visits.
Álvaro García‐Bustillo +11 more
wiley +1 more source
Genotypes and associations with symptoms in primary ciliary dyskinesia [PDF]
, 2023 Eva S.L. Pedersen +7 more
openalex +1 more source
Movement Disorders in Neuromyelitis Optica Spectrum Disorder: A Systematic Review
Movement Disorders Clinical Practice, EarlyView.Abstract Background Several movement disorders (MD) have been reported to occur in neuromyelitis optica spectrum disorder (NMOSD). No extensive review has addressed the whole spectrum of MD in NMOSD. Objective This article aims to review MD in NMOSD, describing its prevalence and features.
Luciana A.F. Bringel +18 more
wiley +1 more source